Masimo Reports FDA 510(k) Clearance For Root With Noninvasive Blood Pressure

(RTTNews) - Masimo (MASI) announced FDA 510(k) clearance for noninvasive blood pressure and temperature measurements for the Root patient monitoring and connectivity platform. The company said, with the addition of noninvasive blood pressure and temperature to the Root platform, clinicians can easily and automatically chart vital signs data directly from Root.

Joe Kiani, CEO of Masimo, said: "We designed Root to do for patient monitoring what PCs did for computing. By creating a platform which allows third-party measurement expansion, with an intuitive user interface and network connectivity, we hope to speed up innovation while reducing the cost of monitoring, as well as potentially improving patient care and patient safety."